Monday, August 31, 2026

Tenaris S.A. And 3 Other Stocks Have Very High Payout Ratio

ViaNews Editorial Team

November 7, 2021

Tenaris S.A. And 3 Other Stocks Have Very High Payout Ratio

(VIANEWS) - National Health Investors (NHI), Tenaris S.A. (TS), PIMCO Dynamic Income Fund (PDI) are the highest payout ratio stocks on this list.

Here's the data we've collected of stocks with a high payout ratio at the moment. The payout ratio in itself isn't a guarantee of a future good investment but it's an indicator of whether dividends are being paid and how the company chooses to issue them.

When investigating a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.

1. National Health Investors (NHI)

124.23% Payout Ratio

Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments.

Volume

Today's last reported volume for National Health Investors is 213696, 32.79% below its average volume of 317984.

As maintained by Morningstar, Inc., the next dividend payment is on Jun 28, 2021, the estimated forward annual dividend rate is 3.6 and the estimated forward annual dividend yield is 5.25%.

National Health Investors's sales growth this year is expected to be negative 9% and 4.9% for next year.

Year-on-year quarterly revenue growth declined by 3.1%, now sitting on 327.13M for the twelve trailing months.

National Health Investors's sales growth is negative 12.1% for the present quarter and negative 6.7% for the next. The company's growth estimates for the ongoing quarter and the next is 27.4% and 48.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.4%.

Volatility

National Health Investors's last day, week, and month's current volatility was 0.61%, 1.80%, and 1.13%, respectively.

National Health Investors's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.12% (day), 3.01% (last week), and 2.09% (last month), respectively.

National Health Investors's Stock Yearly Top and Bottom Value

National Health Investors's stock is valued at $53.32 at 07:23 EST, way under its 52-week high of $78.56 and above its 52-week low of $51.78.

National Health Investors's Moving Average

National Health Investors's worth is under its 50-day moving average of $55.36 and way under its 200-day moving average of $63.53.

2. Tenaris S.A. (TS)

52.5% Payout Ratio

Tenaris S.A., through its subsidiaries, produces and sells seamless and welded steel tubular products; and provides related services for the oil and gas industry, and other industrial applications.

Volume

Today's last reported volume for Tenaris S.A. is 5294700, 153.24% above its average volume of 2090720.

As stated by Morningstar, Inc., the next dividend payment is on May 23, 2021, the estimated forward annual dividend rate is 0.42 and the estimated forward annual dividend yield is 2.15%.

Tenaris S.A.'s sales growth this year is expected to be 15.3% and 18.3% for next year.

Year-on-year quarterly revenue growth grew by 23.2%, now sitting on 4.85B for the twelve trailing months.

Tenaris S.A.'s sales growth is 59.2% for the present quarter and 48.8% for the next. The company's growth estimates for the present quarter and the next is 666.7% and 100%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.03%.

Volatility

Tenaris S.A.'s last day, week, and month's current volatility was 6.06%, 2.74%, and 1.76%, respectively.

Tenaris S.A.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.49% (day), 2.83% (last week), and 2.11% (last month), respectively.

Tenaris S.A.'s Stock Yearly Top and Bottom Value

Tenaris S.A.'s stock is valued at $23.99 at 07:23 EST, under its 52-week high of $24.23 and way higher than its 52-week low of $11.77.

Tenaris S.A.'s Moving Average

Tenaris S.A.'s worth is above its 50-day moving average of $21.81 and way higher than its 200-day moving average of $21.57.

3. PIMCO Dynamic Income Fund (PDI)

52.09% Payout Ratio

PIMCO Dynamic Income Fund is a close ended fixed income mutual fund launched and managed by Allianz Global Investors Fund Management LLC.

Volume

Today's last reported volume for PIMCO Dynamic Income Fund is 293234, 13.62% below its average volume of 339478.

As claimed by Morningstar, Inc., the next dividend payment is on Nov 9, 2021, the estimated forward annual dividend rate is 2.65 and the estimated forward annual dividend yield is 9.79%.

Volatility

PIMCO Dynamic Income Fund's last day, week, and month's current volatility was 0.19%, 0.32%, and 0.37%, respectively.

PIMCO Dynamic Income Fund's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.41% (day), 0.64% (last week), and 0.79% (last month), respectively.

PIMCO Dynamic Income Fund's Stock Yearly Top and Bottom Value

PIMCO Dynamic Income Fund's stock is valued at $27.12 at 07:23 EST, under its 52-week high of $29.75 and higher than its 52-week low of $24.80.

PIMCO Dynamic Income Fund's Moving Average

PIMCO Dynamic Income Fund's value is above its 50-day moving average of $26.69 and below its 200-day moving average of $28.14.

4. MetLife (MET)

37.42% Payout Ratio

MetLife, Inc. engages in the insurance, annuities, employee benefits, and asset management businesses worldwide.

Volume

Today's last reported volume for MetLife is 4300850, 4.03% below its average volume of 4481830.

As maintained by Morningstar, Inc., the next dividend payment is on Aug 8, 2021, the estimated forward annual dividend rate is 1.92 and the estimated forward annual dividend yield is 3.09%.

MetLife's sales growth this year is expected to be negative 0.9% and 0.9% for next year.

Year-on-year quarterly revenue growth grew by 31.4%, now sitting on 69.52B for the twelve trailing months.

MetLife's sales growth is 1.9% for the present quarter and negative 16.2% for the next. The company's growth estimates for the current quarter and the next is negative 4.6% and negative -17.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.39%.

Volatility

MetLife's last day, week, and month's current volatility was 2.14%, 2.29%, and 1.19%, respectively.

MetLife's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.68% (day), 3.88% (last week), and 2.14% (last month), respectively.

MetLife's Stock Yearly Top and Bottom Value

MetLife's stock is valued at $63.99 at 07:23 EST, under its 52-week high of $67.68 and way above its 52-week low of $40.08.

MetLife's Moving Average

MetLife's worth is higher than its 50-day moving average of $63.67 and higher than its 200-day moving average of $62.28.

Previous days news about MetLife (MET)

  • At metlife, life insurance claims rise for younger people dying from Covid-19. According to The Wall Street Journal on Wednesday, 3 November, "Covid-19 cut into third-quarter results at MetLife Inc. as deaths linked to the Delta variant increased for people in their working years."
ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com